Last reviewed · How we verify
NCT04438993: COVICARE
The COVID-19 Disease and CARdiac Events Study
trial in COVID in 100 participants. Completed in 29 January 2021.
29 January 2021
Quick facts
| Lead sponsor | NHS Lanarkshire |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 29 May 2020 |
| Primary completion | 29 January 2021 |
| Estimated completion | 29 January 2021 |
| Sites | 1 location across United Kingdom |
Conditions studied
- COVID — all drugs for COVID →
- Coronavirus — all drugs for Coronavirus →
Sponsor
NHS Lanarkshire
Who can join
18 and older, any sex, with COVID or Coronavirus. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
An observational study of consecutive patients testing positive for COVID-19 who require admission to hospital to determine the degree of myocardial injury through biomarkers and echocardiography and the impact of this on cardiovascular outcomes. The COVID-19 disease and CARdiac Events study (COVICARE).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04438993
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for COVID
Currently open trials in the same condition.
- NCT06744660 — Clinical Validation of the Aptitude Medical Systems Metrix COVID-19 Test · NA · recruiting
- NCT04910269 — Outpatient Treatment With Anti-Coronavirus Immunoglobulin · Phase 3 · recruiting
- NCT04447833 — Mesenchymal Stromal Cell Therapy For The Treatment Of Acute Respiratory Distress Syndrome · Phase 1 · active not recruiting
- NCT04351347 — The Efficacy of Ivermectin in Larger Doses in COVID-19 Treatment · Phase 2, PHASE3 · recruiting
- NCT04382846 — Novel Regimens in COVID-19 Treatment · Phase 3 · recruiting
Other NHS Lanarkshire trials
Trials by the same sponsor.
- NCT06908148 — SALACIA: SALvesAn vs Conventional Management of dIAbetic Foot Wounds · NA · not yet recruiting
- NCT05339191 — Compassionate Imagery for People With An Intellectual Disability · NA · completed
- NCT03659955 — Autologous Blood Treatment for Ocular Surface Disease · NA · completed
- NCT02841969 — Management of the Diabetic Foot Using Electrolysed Water · NA · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04438993 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by NHS Lanarkshire
- Last refreshed: 21 April 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04438993.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing